Prices as of 2025-11-26 16:20:40 ET
Ticker Appearances
Daily Technical Strategy
SPX, RSP, RSPH and Gold/Bitcoin Ratio in Focus
^SPX has now pushed back to new all-time high territory this week, which sets up for a push up to 6749 in the short run,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
SPX, RSP, RSPH and Gold/Bitcoin Ratio in Focus
^SPX has now pushed back to new all-time high territory this week, which sets up for a push up to 6749 in the short run,...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 5 free reports this month.
Visitor: ed92af-417ac8-e69d04-4c2746-2864af Array ( [cookie] => ed92af-417ac8-e69d04-4c2746-2864af [current_usage] => 5 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.54 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In ed92af-417ac8-e69d04-4c2746-2864af
Already have an account? Sign In ed92af-417ac8-e69d04-4c2746-2864af